Moser Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-135
Closed -$7.64K 164
2024
Q4
$7.64K Hold
135
﹤0.01% 123
2024
Q3
$6.99K Hold
135
﹤0.01% 126
2024
Q2
$5.61K Hold
135
﹤0.01% 132
2024
Q1
$7.32K Buy
+135
New +$6.88K ﹤0.01% 126
2021
Q2
Sell
-200
Closed -$13K 140
2021
Q1
$13K Hold
200
0.01% 101
2020
Q4
$12K Hold
200
0.01% 104
2020
Q3
$12K Hold
200
0.01% 103
2020
Q2
$12K Hold
200
0.01% 99
2020
Q1
$11K Hold
200
0.01% 104
2019
Q4
$13K Buy
+200
New +$11.5K 0.01% 120

Other funds holding BMY

Moser Wealth Advisors's BMY Position: Q1 2025 in Review

Moser Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 135 shares — an estimated $7.64K sold.

Moser Wealth Advisors first reported a position in BMY in Q4 2019 and held it in 10 quarters. The position peaked at $13K in Q1 2021. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Moser Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • Moser Wealth Advisors sold 135 Bristol-Myers Squibb shares in Q1 2025, an estimated $7.64K.
  • Moser Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 10 quarters.
  • Moser Wealth Advisors's Bristol-Myers Squibb position peaked at $13K in Q1 2021.
  • 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Moser Wealth Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.